Concepedia

Katy L. Simonsen

KL

17

Publications

3K

Citations

15

H-Index

1995

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Purdue University West Lafayette

Harvard University

Brigham and Women's Hospital

Melanoma Institute Australia

Katy L. Simonsen is an author at Bristol-Myers Squibb (United States) specializing in public health, statistics, and biostatistics.

Top concepts

Public HealthStatisticsMedicineBiostatisticsEngineeringStatistical GeneticsGeneticsPopulation GeneticsStatistical InferenceHealth

Publications per year

1995–2021

17

Publications

17

Implementing false discovery rate control: increasing your power

Koen J. F. Verhoeven, Katy L. Simonsen, Lauren M. McIntyre · Oikos · 2005 · 948 citations · Full text

Artificial Intelligence, Quantitative Methods, Engineering +17

Properties of statistical tests of neutrality for DNA polymorphism data.

Katy L. Simonsen, Gary A. Churchill, Charles F. Aquadro · Genetics · 1995 · 698 citations · Full text

Genetics, Dna Analysis, Human Polymorphism +18

Effects of<i>CYP2C19</i>Genotype on Outcomes of Clopidogrel Treatment

Guillaume Paré, Shamir R. Mehta, Salim Yusuf et al. · New England Journal of Medicine · 2010 · 530 citations · Full text

Polymorphism in KIF6 Gene and Benefit From Statins After Acute Coronary Syndromes

Olga A. Iakoubova, Marc S. Sabatine, Charles M. Rowland et al. · Journal of the American College of Cardiology · 2008 · 150 citations

Inflammation, Benefit From Statins, Cardiovascular Disease +15

Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047 (CA224-047).

Evan J. Lipson, Hussein Tawbi, Dirk Schadendorf et al. · Journal of Clinical Oncology · 2021 · 149 citations

Surgical Oncology, Immune Regulation, Immunology +22

Rows per page

1–5 of 17